3.98
price down icon0.25%   -0.01
after-market Dopo l'orario di chiusura: 3.98
loading
Precedente Chiudi:
$3.99
Aprire:
$3.96
Volume 24 ore:
20,848
Relative Volume:
0.21
Capitalizzazione di mercato:
$75.58M
Reddito:
-
Utile/perdita netta:
$-24.05M
Rapporto P/E:
-1.8512
EPS:
-2.15
Flusso di cassa netto:
$-17.78M
1 W Prestazione:
-4.33%
1M Prestazione:
+10.25%
6M Prestazione:
+31.79%
1 anno Prestazione:
-22.27%
Intervallo 1D:
Value
$3.93
$4.04
Intervallo di 1 settimana:
Value
$3.86
$4.36
Portata 52W:
Value
$2.0278
$6.48

Envveno Medical Corporation Stock (NVNO) Company Profile

Name
Nome
Envveno Medical Corporation
Name
Telefono
949-261-2900
Name
Indirizzo
70 DOPPLER, IRVINE
Name
Dipendente
37
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-01
Name
Ultimi documenti SEC
Name
NVNO's Discussions on Twitter

Confronta NVNO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NVNO
Envveno Medical Corporation
3.98 75.58M 0 -24.05M -17.78M -2.15
Medical Devices icon
ABT
Abbott Laboratories
136.26 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.78 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.74 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.75 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.18 44.46B 5.54B 4.18B 623.10M 7.00

Envveno Medical Corporation Borsa (NVNO) Ultime notizie

pulisher
Jun 09, 2025

Jane Street Group LLC Acquires New Shares in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoV - GuruFocus

Jun 07, 2025
pulisher
Jun 07, 2025

Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting - The Oklahoman

Jun 07, 2025
pulisher
Jun 06, 2025

enVVeno Medical (NVNO) Showcases Promising Two-Year Data for Ven - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoValve Trial Results | NVNO Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pi - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

enVVeno Medical announces two-year data from VenoValve pivotal study - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

enVVeno Medical announces interim two-year follow-up data on VenoValve trial - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting | NVNO Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

VenoValve Shows 83% Success Rate in 2-Year Trial Data, FDA Decision Due 2025 | NVNO Stock News - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

enVVeno Medical Corporation (NASDAQ:NVNO) Short Interest Up 19.4% in May - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

NVNBWForm FWPFiling under Securities Act Rules 163/433 of free writing prospectuses - mx.advfn.com

Jun 05, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Raises Holdings in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Jun 04, 2025
pulisher
Jun 01, 2025

enVVeno Medical surges 70% following InvestingPro’s Fair Value signal By Investing.com - Investing.com India

Jun 01, 2025
pulisher
May 20, 2025

enVVeno Medical appoints Jennifer Bright as financial chief - MSN

May 20, 2025
pulisher
May 20, 2025

enVVeno Medical Appoints New Chief Financial Officer - TipRanks

May 20, 2025
pulisher
May 19, 2025

enVVeno Medical appoints new CFO amid growth phase By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

EnVVeno Medical Names Jennifer Bright as CFO - Orange County Business Journal

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical (NVNO) Appoints New CFO Jennifer Bright | NVNO Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical (NVNO) Appoints New CFO, Jennifer Bright | NVNO Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical (NVNO) Appoints New CFO Jennifer Bright | NVNO S - GuruFocus

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical appoints Jennifer Bright as CFO - TipRanks

May 19, 2025
pulisher
May 19, 2025

EnVVeno Medical Names Jennifer Bright CFO - marketscreener.com

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical appoints new CFO amid growth phase - Investing.com

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer | NVNO Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer - ACCESS Newswire

May 19, 2025
pulisher
May 19, 2025

Dimensional Fund Advisors LP Decreases Stake in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

May 19, 2025
pulisher
May 14, 2025

EnVVeno has first-in-human valve data, expects FDA decision this year - MassDevice

May 14, 2025
pulisher
May 13, 2025

NVNO's VenoValve Shows Promising Three-Year Outcomes in Publishe - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Three-Year VenoValve(R) First-in-Human Trial Data Published in t - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Three-year VenoValve first-in-human trial data show high patency rate - Venous News

May 13, 2025
pulisher
May 13, 2025

enVVeno Medical (NVNO) Reveals Promising Three-Year VenoValve Ou - GuruFocus

May 13, 2025
pulisher
May 13, 2025

enVVeno Medical publishes three-year VenoValve data - TipRanks

May 13, 2025
pulisher
May 13, 2025

enVVeno Medical (NVNO) Reveals Promising Three-Year VenoValve Outcomes | NVNO Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery - ACCESS Newswire

May 13, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Stake in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

May 03, 2025
pulisher
May 01, 2025

NVNO: Financial Position Supports Key Developments Ahead | NVNO Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

enVVeno Medical (NVNO) Eyes Commercial Transition with VenoValve - GuruFocus

May 01, 2025
pulisher
May 01, 2025

enVVeno Medical (NVNO) Eyes Commercial Transition with VenoValve Progress | NVNO Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

enVVeno Medical Reports First Quarter 2025 Financial Results and - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24 - Corsicana Daily Sun

May 01, 2025
pulisher
May 01, 2025

enVVeno Medical Reports Strong Q1 Financials with $38.9M War Chest for VenoValve FDA Launch - Stock Titan

May 01, 2025
pulisher
Apr 29, 2025

enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 29, 2025

JPMorgan Chase & Co. Buys New Shares in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Apr 29, 2025

Envveno Medical Corporation Azioni (NVNO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Envveno Medical Corporation Azioni (NVNO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Gray Robert
Director
Dec 31 '24
Buy
2.94
3,500
10,290
11,155
Shrivastava Sanjay
Director
Dec 24 '24
Buy
2.90
5,400
15,660
9,288
Jenusaitis Matthew
Director
Dec 19 '24
Buy
2.53
9,620
24,339
16,545
BERMAN ROBERT ANDREW
Chief Executive Officer
Dec 19 '24
Buy
2.55
12,000
30,600
222,236
$299.99
price down icon 4.52%
medical_devices PHG
$24.20
price up icon 0.92%
medical_devices STE
$242.66
price up icon 1.02%
$83.58
price down icon 4.25%
$75.95
price up icon 2.54%
medical_devices EW
$77.18
price down icon 1.32%
Capitalizzazione:     |  Volume (24 ore):